COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices
Join your dermatology colleagues and thought leaders as we examine the hidden impact of COVID-19 on dermatologists and providers, including new and small private practices, emotional wellbeing and the evolving priorities placed on providers during the global coronavirus pandemic. Panelists will discuss their first-hand, personal experience living with COVID-19 and ways it has impacted their physical and emotional health, practice and personal life.
Discussion and guidance will be given on simple steps you can take in the wellness sphere, crisis management and return to practice concepts for both large and small dermatology practices.
Moderators
- Richard G. Fried, MD, PhD (Board Certified Dermatologist & Clinical Psychologist, Clinical Director, Yardley Dermatology Associates)
Panelists
- Evan Rieder, MD (Board Certified Dermatologist & Psychiatrist, NYU Langone Health)
- Paul Jarrod Frank, MD (Chief Medical Officer & Founder, PFRANKMD)
- Melissa Kanchanapoomi Levin, MD (Founder, Entière Dermatology)
You May Also Like
The Role of JAK Inhibitors in the Treatment of Cutaneous Lupus Erythematosus: A Review
JDD Article Highlight Could targeting the JAK/STAT pathway redefine how we approach cutaneous lupus erythematosus (CLE)? Spanning acute (ACLE), subacute (SCLE), and chronic (CCLE) forms, CLE presents a spectrum of…
Delayed Inflammatory Reactions to Hyaluronic Acid Fillers: A Case Series of Novel Associations
JDD Article Highlight Hyaluronic acid (HA) fillers are widely used in cosmetic dermatology, but delayed immunologic reactions (DIRs) remain a rare yet important complication. While common triggers like infections are…
